Armin Farahvash
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Armin Farahvash has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
- Michelle Chae Min Lee
Division of Gastroenterology, Department of Internal Medicine, Thunder Bay Regional Health Sciences Centre, NOSM University , Thunder Bay, Ontario
3 shared publications - Rajeev H. Muni
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada
3 shared publications Dana J. Philpott
Department of Immunology, University of Toronto, Toronto, ON, Canada
2 shared publicationsJessica Tsalikis
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
2 shared publications- Jonathan Andrew Micieli
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada
2 shared publications - Mena Abdel-Nour
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
2 shared publications
Latest Publications
- 13 October 2026
- Published by Wolters Kluwer Health in Menopause
Trends of menopausal hormone therapy across Canadian provinces in 2018-2023
Objectives: Menopausal hormone therapy (MHT) is guideline-recommended as the first-line treatment for vasomotor symptoms in women without contraindications. Despite this, use of MHT remains low with persistent concerns about safety following the Women’s Health Initiative. Contemporary population-level data on the trends of MHT use in Canada over the years, as well as differences across provinces, are limited. This study examines recent trends and interprovincial variation in MHT expenditure among Canadian provinces. Methods: We conducted a retrospective time-series study of MHT dispensing trends across Canadian provinces (December 2017-November 2023) using IQVIA CompuScript. Use was standardized to defined daily dose (DDD) as set by the World Health Organization. The purchasing data is shown as DDD per 1000 women per day, normalized by provincial population of women aged 45-65 years for oral, transdermal, and vaginal MHT. Results: National MHT use increased from 59.1 to 83.4 DDD/1000 women/day during the study period. Growth was driven by vaginal (14.9-29.2) and transdermal MHT (18.4-26.8) formulations, while use of oral MHT remained stable (25.8-27.3). In 2023, Quebec had the highest rate of MHT dispensing at 162 DDD/1000 women/day, followed by British Columbia and Nova Scotia (84.3 and 83.1 DDD/1000 women/day, respectively). Conclusions: MHT use in Canada is increasing but remains modest and variable across formulations and provinces. Markedly higher use of MHT in Quebec may be partly explained by a more comprehensive drug coverage. Our findings highlight gaps in uptake of guideline-recommended therapy and provide a foundation for future research and policy considerations.
- 13 October 2026
- Published by Wolters Kluwer Health in Menopause
Trends of menopausal hormone therapy across Canadian provinces in 2018-2023
Objectives: Menopausal hormone therapy (MHT) is guideline-recommended as the first-line treatment for vasomotor symptoms in women without contraindications. Despite this, use of MHT remains low with persistent concerns about safety following the Women’s Health Initiative. Contemporary population-level data on the trends of MHT use in Canada over the years, as well as differences across provinces, are limited. This study examines recent trends and interprovincial variation in MHT expenditure among Canadian provinces. Methods: We conducted a retrospective time-series study of MHT dispensing trends across Canadian provinces (December 2017-November 2023) using IQVIA CompuScript. Use was standardized to defined daily dose (DDD) as set by the World Health Organization. The purchasing data is shown as DDD per 1000 women per day, normalized by provincial population of women aged 45-65 years for oral, transdermal, and vaginal MHT. Results: National MHT use increased from 59.1 to 83.4 DDD/1000 women/day during the study period. Growth was driven by vaginal (14.9-29.2) and transdermal MHT (18.4-26.8) formulations, while use of oral MHT remained stable (25.8-27.3). In 2023, Quebec had the highest rate of MHT dispensing at 162 DDD/1000 women/day, followed by British Columbia and Nova Scotia (84.3 and 83.1 DDD/1000 women/day, respectively). Conclusions: MHT use in Canada is increasing but remains modest and variable across formulations and provinces. Markedly higher use of MHT in Quebec may be partly explained by a more comprehensive drug coverage. Our findings highlight gaps in uptake of guideline-recommended therapy and provide a foundation for future research and policy considerations.
- Open Access
- 24 June 2025
- Published by Elsevier in Primary Care Diabetes
- Vol. 19 (5) , 512-516
Pattern of semaglutide prescription in a real-world Canadian patient cohort
- 24 June 2025
- Published by Elsevier in Primary Care Diabetes
- Vol. 19 (5) , 512-516
Open AccessPattern of semaglutide prescription in a real-world Canadian patient cohort
- 7 May 2025
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (7) , 2056-2057
Response to the Letter to the Editor: “AI-Assisted IBD Severity Classification: A Critical Perspective on Current Evidence and Next Steps”
- 7 May 2025
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 31 (7) , 2056-2057
Response to the Letter to the Editor: “AI-Assisted IBD Severity Classification: A Critical Perspective on Current Evidence and Next Steps”
- 31 March 2025
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
Artificial Intelligence for Classification of Endoscopic Severity of Inflammatory Bowel Disease: A Systematic Review and Critical Appraisal
Background: Endoscopic scoring indices for ulcerative colitis and Crohn’s disease are subject to inter-endoscopist variability. There is increasing interest in the development of deep learning models to standardize endoscopic assessment of intestinal diseases. Here, we summarize and critically appraise the literature on artificial intelligence-assisted endoscopic characterization of inflammatory bowel disease severity. Methods: A systematic search of Ovid MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and IEEE Xplore was performed to identify reports of AI systems used for endoscopic severity classification of IBD. Selected studies were critically appraised for methodological and reporting quality using APPRAISE-AI. Results: Thirty-one studies published between 2019 and 2024 were included. Of 31 studies, 28 studies examined endoscopic classification of ulcerative colitis and 3 examined Crohn’s disease. Researchers sought to accomplish a wide range of classification tasks, including binary and multilevel classification, based on still images or full-length colonoscopy videos. Overall scores for study quality ranged from 41 (moderate quality) to 64 (high quality) out of 100, with 28 out of 31 studies within the moderate quality range. The highest-scoring domains were clinical relevance and reporting quality, while the lowest-scoring domains were robustness of results and reproducibility. Conclusions: Multiple AI models have demonstrated the potential for clinical translation for ulcerative colitis. Research concerning the endoscopic severity assessment of Crohn’s disease is limited and should be further explored. More rigorous external validation of AI models and increased transparency of data and codes are needed to improve the quality of AI studies.
- 31 March 2025
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
Artificial Intelligence for Classification of Endoscopic Severity of Inflammatory Bowel Disease: A Systematic Review and Critical Appraisal
Background: Endoscopic scoring indices for ulcerative colitis and Crohn’s disease are subject to inter-endoscopist variability. There is increasing interest in the development of deep learning models to standardize endoscopic assessment of intestinal diseases. Here, we summarize and critically appraise the literature on artificial intelligence-assisted endoscopic characterization of inflammatory bowel disease severity. Methods: A systematic search of Ovid MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and IEEE Xplore was performed to identify reports of AI systems used for endoscopic severity classification of IBD. Selected studies were critically appraised for methodological and reporting quality using APPRAISE-AI. Results: Thirty-one studies published between 2019 and 2024 were included. Of 31 studies, 28 studies examined endoscopic classification of ulcerative colitis and 3 examined Crohn’s disease. Researchers sought to accomplish a wide range of classification tasks, including binary and multilevel classification, based on still images or full-length colonoscopy videos. Overall scores for study quality ranged from 41 (moderate quality) to 64 (high quality) out of 100, with 28 out of 31 studies within the moderate quality range. The highest-scoring domains were clinical relevance and reporting quality, while the lowest-scoring domains were robustness of results and reproducibility. Conclusions: Multiple AI models have demonstrated the potential for clinical translation for ulcerative colitis. Research concerning the endoscopic severity assessment of Crohn’s disease is limited and should be further explored. More rigorous external validation of AI models and increased transparency of data and codes are needed to improve the quality of AI studies.
- 21 July 2024
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 60 (1) , e100-e116
Changes in aqueous and vitreous inflammatory cytokine levels in nonproliferative diabetic retinopathy: systematic review and meta-analysis
- 21 July 2024
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 60 (1) , e100-e116
Changes in aqueous and vitreous inflammatory cytokine levels in nonproliferative diabetic retinopathy: systematic review and meta-analysis
- Open Access
- 10 November 2023
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 72 (2) , 627-630
The prevalence and regional variability of diabetes among nursing home residents in Ontario
- 10 November 2023
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 72 (2) , 627-630
Open AccessThe prevalence and regional variability of diabetes among nursing home residents in Ontario
- Open Access
- 22 May 2022
- Published by SAGE Publications in Plastic Surgery
- Vol. 32 (1) , 158-161
A Computed Tomography Scan Near Miss of an Intraorbital Wooden Foreign Body
When intraorbital wooden foreign bodies are missed, the consequences can be devastating. While the gold standard diagnostic imaging is computed tomography (CT), it has low sensitivity. We present a 61-year-old man with a bamboo injury to his right eye. He underwent two CT scans that failed to raise the possibility of intraorbital foreign bodies. Upon additional review, a rectangular-shaped pocket of air was identified in the orbit which was most consistent with wooden foreign bodies based on the clinical history. A combined mid-lid approach followed by a transconjunctival and transcaruncular extension were employed to remove several wooden splinters. Postoperatively, due to recurrent orbital compartment syndrome, he required a second decompression with an inferior rim osteotomy. He had good recovery at 3 months follow-up. Overall, intraorbital wooden foreign bodies are challenging to diagnose due to imaging limitations. Providing a clear history and suspected diagnosis to radiology is critical for diagnosis.
- 22 May 2022
- Published by SAGE Publications in Plastic Surgery
- Vol. 32 (1) , 158-161
Open AccessA Computed Tomography Scan Near Miss of an Intraorbital Wooden Foreign Body
When intraorbital wooden foreign bodies are missed, the consequences can be devastating. While the gold standard diagnostic imaging is computed tomography (CT), it has low sensitivity. We present a 61-year-old man with a bamboo injury to his right eye. He underwent two CT scans that failed to raise the possibility of intraorbital foreign bodies. Upon additional review, a rectangular-shaped pocket of air was identified in the orbit which was most consistent with wooden foreign bodies based on the clinical history. A combined mid-lid approach followed by a transconjunctival and transcaruncular extension were employed to remove several wooden splinters. Postoperatively, due to recurrent orbital compartment syndrome, he required a second decompression with an inferior rim osteotomy. He had good recovery at 3 months follow-up. Overall, intraorbital wooden foreign bodies are challenging to diagnose due to imaging limitations. Providing a clear history and suspected diagnosis to radiology is critical for diagnosis.
- 7 March 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (7) , E1470-E1478
Impact of tamponade agent on retinal displacement following pars plana vitrectomy for rhegmatogenous retinal detachment repair: a computer simulation model
Purpose: Rhegmatogenous retinal detachment (RRD) repair with silicone oil (SO) tamponade has been observed to cause less retinal displacement than gas tamponade. Here, we assessed the mechanism and theoretical extent of retinal displacement in SO versus air tamponade in pars plana vitrectomy (PPV).Design: Computer simulation model.Methods: Tamponade scale and subretinal scale simulation models previously developed were used to assess the physical forces, fluid dynamics and retinal deformations in SO versus air PPV.Results: When comparing a SO tamponade and an air tamponade occupying 93% of the ocular cavity, the SO tamponade has a Bond number that is an order of magnitude smaller and has a much lower contact angle (99° versus 125°) and contact pressure (0.0230 versus 1.44 mmHg). With a greater contact area and contact pressure, an air tamponade squeezes subretinal fluid away from contact points, displacing the retina by a maximum length of approximately 700 μm in our model. In contrast, for a SO tamponade, the contact pressure is much lower with a very small magnitude of retinal displacement (~ 50 μm).Conclusions: We showed that SO tamponade leads to significantly less retinal displacement than air tamponades. Although we do not recommend the routine use of primary SO because of its several disadvantages compared with gas, our findings can be further utilized to develop novel tamponade agents that minimize the risk of retinal displacement following RRD repair.
- 7 March 2022
- Published by Wiley in Acta Ophthalmologica
- Vol. 100 (7) , E1470-E1478
Impact of tamponade agent on retinal displacement following pars plana vitrectomy for rhegmatogenous retinal detachment repair: a computer simulation model
Purpose: Rhegmatogenous retinal detachment (RRD) repair with silicone oil (SO) tamponade has been observed to cause less retinal displacement than gas tamponade. Here, we assessed the mechanism and theoretical extent of retinal displacement in SO versus air tamponade in pars plana vitrectomy (PPV).Design: Computer simulation model.Methods: Tamponade scale and subretinal scale simulation models previously developed were used to assess the physical forces, fluid dynamics and retinal deformations in SO versus air PPV.Results: When comparing a SO tamponade and an air tamponade occupying 93% of the ocular cavity, the SO tamponade has a Bond number that is an order of magnitude smaller and has a much lower contact angle (99° versus 125°) and contact pressure (0.0230 versus 1.44 mmHg). With a greater contact area and contact pressure, an air tamponade squeezes subretinal fluid away from contact points, displacing the retina by a maximum length of approximately 700 μm in our model. In contrast, for a SO tamponade, the contact pressure is much lower with a very small magnitude of retinal displacement (~ 50 μm).Conclusions: We showed that SO tamponade leads to significantly less retinal displacement than air tamponades. Although we do not recommend the routine use of primary SO because of its several disadvantages compared with gas, our findings can be further utilized to develop novel tamponade agents that minimize the risk of retinal displacement following RRD repair.
- 1 November 2021
- Published by Elsevier in Ophthalmology Retina
- Vol. 5 (11) , 1125-1138
Combined versus Sequential Phacoemulsification and Pars Plana Vitrectomy
- 1 November 2021
- Published by Elsevier in Ophthalmology Retina
- Vol. 5 (11) , 1125-1138
Combined versus Sequential Phacoemulsification and Pars Plana Vitrectomy
- Open Access
- 12 April 2021
- Published by S. Karger AG in Case Reports in Ophthalmology
- Vol. 12 (1) , 174-181
Mitochondrial Neurogastrointestinal Encephalopathy Disease: A Rare Disease Diagnosed in Siblings with Double Vision
Mitochondrial neurogastrointestinal encephalopathy disease (MNGIE) is a rare autosomal recessive condition characterized by gastrointestinal dysmotility, external ophthalmoplegia, leukoencephalopathy, and sensorimotor neuropathy. A 31-year-old man was referred for a 1-year history of horizontal diplopia related to a large exotropia from chronic progressive external ophthalmoplegia. MRI revealed a diffuse leukoencephalopathy and his 3-year history of chronic intermittent diarrhea, cachexia, and diffuse sensory more than motor peripheral neuropathy led to a unifying clinical diagnosis of MNGIE. This was later confirmed with genetic testing, which revealed a homozygous pathogenic mutation in the thymidine phosphorylase (TYMP) gene. His younger brother had an identical clinical syndrome and was similarly diagnosed. MNGIE diagnosis is important to establish to avoid unnecessary invasive testing for gastrointestinal, ophthalmological, and neurological symptoms and to ensure patients receive appropriate nutritional and genetic counselling. Gene therapy offers a potential future therapy for patients with this condition.
- 12 April 2021
- Published by S. Karger AG in Case Reports in Ophthalmology
- Vol. 12 (1) , 174-181
Open AccessMitochondrial Neurogastrointestinal Encephalopathy Disease: A Rare Disease Diagnosed in Siblings with Double Vision
Mitochondrial neurogastrointestinal encephalopathy disease (MNGIE) is a rare autosomal recessive condition characterized by gastrointestinal dysmotility, external ophthalmoplegia, leukoencephalopathy, and sensorimotor neuropathy. A 31-year-old man was referred for a 1-year history of horizontal diplopia related to a large exotropia from chronic progressive external ophthalmoplegia. MRI revealed a diffuse leukoencephalopathy and his 3-year history of chronic intermittent diarrhea, cachexia, and diffuse sensory more than motor peripheral neuropathy led to a unifying clinical diagnosis of MNGIE. This was later confirmed with genetic testing, which revealed a homozygous pathogenic mutation in the thymidine phosphorylase (TYMP) gene. His younger brother had an identical clinical syndrome and was similarly diagnosed. MNGIE diagnosis is important to establish to avoid unnecessary invasive testing for gastrointestinal, ophthalmological, and neurological symptoms and to ensure patients receive appropriate nutritional and genetic counselling. Gene therapy offers a potential future therapy for patients with this condition.